Amlodipine 10mg picture
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine 10mg: Efficacy, Pharmacokinetics, and Clinical Applications
Introduction to Amlodipine 10mg
Amlodipine is a long-acting calcium channel blocker commonly used in the treatment of hypertension and angina. The 10mg dosage is particularly noted for its effectiveness in managing these conditions, providing significant therapeutic benefits.
Efficacy in Angina and Hypertension
Stable Angina Pectoris
Amlodipine 10mg has been shown to significantly improve exercise tolerance and reduce the frequency of angina attacks in patients with stable angina pectoris. In a multicenter double-blind crossover trial, patients treated with amlodipine experienced a notable increase in symptom-limited exercise duration and a decrease in angina attack frequency and nitroglycerin consumption compared to placebo. Another study confirmed these findings, demonstrating that amlodipine effectively reduces myocardial oxygen consumption and may increase myocardial blood flow, thereby improving effort tolerance and delaying the onset of ischemia during exercise.
Hypertension Management
Amlodipine 10mg is also effective in reducing blood pressure in patients with hypertension. A Phase III study in Japanese patients with essential hypertension showed that increasing the dose from 5mg to 10mg resulted in significant reductions in both systolic and diastolic blood pressure, with a higher responder rate compared to the lower dose. Additionally, a comparative study between Asian and Western populations found that titrating amlodipine from 5mg to 10mg significantly decreased blood pressure in both groups, highlighting its broad efficacy across different ethnicities.
Pharmacokinetics of Amlodipine 10mg
Absorption and Bioavailability
The pharmacokinetics of amlodipine 10mg have been extensively studied. Oral administration of a single 10mg dose results in a mean systemic availability of 64% and a mean plasma half-life of approximately 36 hours, allowing for once-daily dosing. A study comparing two formulations of amlodipine 10mg in healthy Chinese male volunteers found that both formulations were bioequivalent, with similar pharmacokinetic profiles and tolerability.
Steady-State Concentrations
Repeated oral administration of amlodipine 10mg once daily leads to steady-state plasma concentrations being reached after seven doses, with an accumulation factor of approximately threefold. This steady-state concentration is maintained with a mean half-life of 45 hours, ensuring consistent therapeutic effects.
Clinical Applications and Combination Therapies
Combination with Beta-Blockers
In patients with stable angina pectoris already on beta-blocker therapy, adding amlodipine 10mg provides additional anti-ischemic and anti-anginal benefits. This combination significantly decreases ST-segment depression and increases ischemia-free workload capacity, reducing the number of anginal attacks without causing significant side effects.
Combination with Other Antihypertensives
Amlodipine 10mg is also effective when combined with other antihypertensive agents. For instance, a single-pill combination of telmisartan 80mg and amlodipine 10mg has been shown to provide superior blood pressure reductions compared to monotherapy with either drug alone, with a comparable safety profile. Additionally, combining amlodipine with atorvastatin not only enhances blood pressure control but also improves endothelial function and metabolic parameters, offering a comprehensive approach to managing hypertension and associated cardiovascular risks.
Conclusion
Amlodipine 10mg is a highly effective and well-tolerated option for the treatment of stable angina pectoris and hypertension. Its pharmacokinetic properties support once-daily dosing, and it can be effectively combined with other cardiovascular medications to enhance therapeutic outcomes. The broad efficacy across different populations and its ability to improve both cardiovascular and metabolic health make amlodipine 10mg a valuable component of cardiovascular disease management.
Sources and full results
Most relevant research papers on this topic